ClinicalTrialsFinder

Recurrent Atypical Chronic Myeloid Leukemia Clinical Trials in Rochester, Minnesota

1 recruitingRochester, Minnesota

Showing 1–1 of 1 trials

Recruiting
Phase 1

Onvansertib for the Treatment of Recurrent or Refractory Chronic Myelomonocytic Leukemia and Myelodysplastic Syndrome/MPN Overlap Neoplasms

Recurrent Chronic Myelomonocytic LeukemiaRefractory Chronic Myelomonocytic LeukemiaRecurrent Myelodysplastic/Myeloproliferative Neoplasm+3 more
Mayo Clinic25 enrolled1 locationNCT05549661